Radiation Pneumonitis in Patients with Non–Small-Cell Lung Cancer Treated with Erlotinib Concurrent with Thoracic Radiotherapy

This publication has 15 references indexed in Scilit:

• The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma
  International Journal of Cancer, 2013
• Radiation-induced lung damage: Etiopathogenesis, clinical features, imaging findings and treatment
  Medicinski Pregled, 2012
• Place de la radiothérapie médiastinale postopératoire dans les cancers pulmonaires non à petites cellules
  Cancer/Radiothérapie, 2011
• Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study
  The Lancet Oncology, 2010
• Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2010
• Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
  The Lancet, 2010
• Epidermal Growth Factor Receptor-Related Tumor Markers and Clinical Outcomes with Erlotinib in Non-small Cell Lung Cancer: An Analysis of Patients from German Centers in the TRUST Study
  Journal of Thoracic Oncology, 2008
• Non-Small Cell Lung Cancer Therapy-Related Pulmonary Toxicity: An Update on Radiation Pneumonitis and Fibrosis
  Seminars in Oncology, 2005
• CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
  Seminars in Radiation Oncology, 2003
• Radiation induced secretion of surfactant from cell cultures of type II pneumocytes: An in vitro model of radiation toxicity
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1984